vs
RADIAN GROUP INC（RDN）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
RADIAN GROUP INC的季度营收约是REPLIGEN CORP的1.5倍（$300.5M vs $197.9M），RADIAN GROUP INC净利率更高（51.5% vs 6.7%，领先44.8%），REPLIGEN CORP同比增速更快（13.6% vs 2.7%），RADIAN GROUP INC自由现金流更多（$115.7M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -0.2%）
瑞迪安集团（Radian Group Inc.）是一家专业的 mortgage 保险公司，业务涵盖抵押贷款保险、风险管控、房地产服务及产权服务等多个板块，为住房金融市场提供完善的配套服务支持，助力行业降低信贷相关风险。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
RDN vs RGEN — 直观对比
营收规模更大
RDN
是对方的1.5倍
$197.9M
营收增速更快
RGEN
高出11.0%
2.7%
净利率更高
RDN
高出44.8%
6.7%
自由现金流更多
RDN
多$98.1M
$17.6M
两年增速更快
RGEN
近两年复合增速
-0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $300.5M | $197.9M |
| 净利润 | $154.8M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 76.2% | 9.0% |
| 净利率 | 51.5% | 6.7% |
| 营收同比 | 2.7% | 13.6% |
| 净利润同比 | 4.4% | 143.9% |
| 每股收益（稀释后） | $1.11 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RDNRGEN
| Q4 25 | $300.5M | $197.9M | ||
| Q3 25 | $303.2M | $188.8M | ||
| Q2 25 | $298.6M | $182.4M | ||
| Q1 25 | $294.8M | $169.2M | ||
| Q4 24 | $292.7M | $174.1M | ||
| Q3 24 | $313.4M | $154.9M | ||
| Q2 24 | $298.6M | $154.1M | ||
| Q1 24 | $301.7M | $151.3M |
净利润RDNRGEN
| Q4 25 | $154.8M | $13.3M | ||
| Q3 25 | $141.4M | $14.9M | ||
| Q2 25 | $141.8M | $14.9M | ||
| Q1 25 | $144.6M | $5.8M | ||
| Q4 24 | $148.3M | $-30.3M | ||
| Q3 24 | $151.9M | $-654.0K | ||
| Q2 24 | $151.9M | $3.3M | ||
| Q1 24 | $152.4M | $2.1M |
毛利率RDNRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | 97.2% | 50.0% | ||
| Q1 25 | 97.0% | 53.6% | ||
| Q4 24 | 96.6% | 26.1% | ||
| Q3 24 | 97.0% | 50.0% | ||
| Q2 24 | 96.8% | 49.8% | ||
| Q1 24 | 96.9% | 49.5% |
营业利润率RDNRGEN
| Q4 25 | 76.2% | 9.0% | ||
| Q3 25 | 65.5% | 8.9% | ||
| Q2 25 | 58.6% | 7.6% | ||
| Q1 25 | 63.9% | 3.9% | ||
| Q4 24 | 83.6% | -17.7% | ||
| Q3 24 | 68.4% | -5.1% | ||
| Q2 24 | 63.0% | 1.0% | ||
| Q1 24 | 65.8% | 1.3% |
净利率RDNRGEN
| Q4 25 | 51.5% | 6.7% | ||
| Q3 25 | 46.7% | 7.9% | ||
| Q2 25 | 47.5% | 8.2% | ||
| Q1 25 | 49.0% | 3.4% | ||
| Q4 24 | 50.7% | -17.4% | ||
| Q3 24 | 48.5% | -0.4% | ||
| Q2 24 | 50.9% | 2.2% | ||
| Q1 24 | 50.5% | 1.4% |
每股收益（稀释后）RDNRGEN
| Q4 25 | $1.11 | $0.24 | ||
| Q3 25 | $1.03 | $0.26 | ||
| Q2 25 | $1.02 | $0.26 | ||
| Q1 25 | $0.98 | $0.10 | ||
| Q4 24 | $0.97 | $-0.55 | ||
| Q3 24 | $0.99 | $-0.01 | ||
| Q2 24 | $0.98 | $0.06 | ||
| Q1 24 | $0.98 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.8M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $4.8B | $2.1B |
| 总资产 | $8.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资RDNRGEN
| Q4 25 | $24.8M | $767.6M | ||
| Q3 25 | $15.3M | $748.7M | ||
| Q2 25 | $22.1M | $708.9M | ||
| Q1 25 | $24.2M | $697.2M | ||
| Q4 24 | $19.2M | $757.4M | ||
| Q3 24 | $28.1M | $784.0M | ||
| Q2 24 | $13.8M | $809.1M | ||
| Q1 24 | $27.0M | $780.6M |
总债务RDNRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益RDNRGEN
| Q4 25 | $4.8B | $2.1B | ||
| Q3 25 | $4.7B | $2.1B | ||
| Q2 25 | $4.5B | $2.1B | ||
| Q1 25 | $4.6B | $2.0B | ||
| Q4 24 | $4.6B | $2.0B | ||
| Q3 24 | $4.7B | $2.0B | ||
| Q2 24 | $4.5B | $2.0B | ||
| Q1 24 | $4.4B | $2.0B |
总资产RDNRGEN
| Q4 25 | $8.1B | $2.9B | ||
| Q3 25 | $8.2B | $2.9B | ||
| Q2 25 | $9.6B | $2.9B | ||
| Q1 25 | $8.8B | $2.9B | ||
| Q4 24 | $8.7B | $2.8B | ||
| Q3 24 | $8.4B | $2.8B | ||
| Q2 24 | $8.1B | $2.9B | ||
| Q1 24 | $7.8B | $2.8B |
负债/权益比RDNRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $119.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $115.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 38.5% | 8.9% |
| 资本支出强度资本支出/营收 | 1.4% | 4.1% |
| 现金转化率经营现金流/净利润 | 0.77× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-174.8M | $93.9M |
8季度趋势，按日历期对齐
经营现金流RDNRGEN
| Q4 25 | $119.9M | $25.7M | ||
| Q3 25 | $358.4M | $48.1M | ||
| Q2 25 | $-713.3M | $28.6M | ||
| Q1 25 | $67.8M | $15.0M | ||
| Q4 24 | $-663.6M | $39.2M | ||
| Q3 24 | $-237.9M | $49.3M | ||
| Q2 24 | $-207.3M | $42.2M | ||
| Q1 24 | $51.0M | $44.7M |
自由现金流RDNRGEN
| Q4 25 | $115.7M | $17.6M | ||
| Q3 25 | $357.6M | $43.4M | ||
| Q2 25 | $-714.6M | $21.5M | ||
| Q1 25 | $66.6M | $11.4M | ||
| Q4 24 | $-665.1M | $33.6M | ||
| Q3 24 | $-239.2M | $42.3M | ||
| Q2 24 | $-208.3M | $37.4M | ||
| Q1 24 | $49.5M | $36.4M |
自由现金流率RDNRGEN
| Q4 25 | 38.5% | 8.9% | ||
| Q3 25 | 117.9% | 23.0% | ||
| Q2 25 | -239.4% | 11.8% | ||
| Q1 25 | 22.6% | 6.8% | ||
| Q4 24 | -227.3% | 19.3% | ||
| Q3 24 | -76.3% | 27.3% | ||
| Q2 24 | -69.8% | 24.3% | ||
| Q1 24 | 16.4% | 24.0% |
资本支出强度RDNRGEN
| Q4 25 | 1.4% | 4.1% | ||
| Q3 25 | 0.3% | 2.5% | ||
| Q2 25 | 0.4% | 3.9% | ||
| Q1 25 | 0.4% | 2.1% | ||
| Q4 24 | 0.5% | 3.2% | ||
| Q3 24 | 0.4% | 4.5% | ||
| Q2 24 | 0.4% | 3.1% | ||
| Q1 24 | 0.5% | 5.5% |
现金转化率RDNRGEN
| Q4 25 | 0.77× | 1.93× | ||
| Q3 25 | 2.53× | 3.23× | ||
| Q2 25 | -5.03× | 1.92× | ||
| Q1 25 | 0.47× | 2.57× | ||
| Q4 24 | -4.47× | — | ||
| Q3 24 | -1.57× | — | ||
| Q2 24 | -1.36× | 12.70× | ||
| Q1 24 | 0.34× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
